Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy
作者：Zhipeng Sun1 and Nengwei Zhang2 来源：
日期：2017-11-15
导读
Abstract Background: In the clinical practice of neoadjuvant chemotherapy, response markers are very important. We aimed o investigate whether tumor markers CEA(carcino-embryonic antigen), CA19-9(carbohydrate antigen 19–9), CA72-4(carbohydrate antigen 72
Background: In the clinical practice of Neoadjuvant chemotherapy, response markers are very important. We aimed
o investigate whether tumor markers CEA(carcino-embryonic antigen), CA19-9(carbohydrate antigen 19–9), CA72-4
(carbohydrate antigen 72–4), and CA125(carbohydrate antigen 125) can be used to evaluate the response to
neoadjuvant chemotherapy, and to evaluate the diagnosis and prognosis value of four tumor markers in the patients of Gastric cancer.
分享：
相关文章
评论
我要跟帖发表
回复 小鸭梨：
发表
